Monno R | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Monno R

Scientific Affairs Department, Chiesi Farmaceutici S.p.A., Parma Italy


Raffaella Monno is the Head of Real World Evidence, R&D Global Clinical Development at Chiesi Pharmaceuticals. Additionally, Raffaella Monno has had 1 past job as the Head of Intelligence & New Product Planning, Corporate Marketing at Chiesi Pharmaceuticals. Unique mix of scientific and commercial competences across multiple therapeutic areas; drug development process knowledge and pharmaceutical scenario understanding; hands-on experience with leadership roles in scientific affairs.

Extrafine Beclometasone Dipropionate and Formoterol in Single and Separate Inhalers

The aim of this study was to evaluate the pharmacokinetics and pharmacodynamics of single administration of extrafine beclometasone (BDP)/formoterol hydrofluoroalkane (HFA) (Foster®, Chiesi Farmaceutici S.p.A., Italy) by pressurized metered dose inhaler (pMDI) in healthy volunteers, compared to the free combination of extrafine BDP pMDI (Q... Read More»

Piccinno A, Poli G, Monno R, Goethals F, Nollevaux F and Acerbi D

Research Article: Clin Pharmacol Biopharm 2012, 1:102

DOI: 10.4172/2167-065X.1000102

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF